Work

A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer

Year: 2017

Type: article

Study design: Clinical Trial

Source: Clinical Breast Cancer

DOI: 10.1016/j.clbc.2017.04.010

Authors: Theresa L. Werner, Abhijit Ray, John G. Lamb, Matthew VanBrocklin, Kristin Hueftle, Adam L. Cohen, Anna C. Beck, Saundra S. Buys, Donna L. Dyess, Thomas W. Butler, Theresa L. Dumlao, Leigh Neumayer, Hung T. Khong

Institutions: University of Utah, Huntsman Cancer Institute, USA Mitchell Cancer Institute, University of South Alabama, Banner MD Anderson Cancer Center, University of Arizona, Moffitt Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2608820756

FWCI: 0.329

Cites: 22

Cited by: 9

Related to: 10